Table 2 Clinical, biochemical and CMR parameters at baseline and follow up.
Variable | Baseline [N = 24] | Follow Up [N = 24] | P value |
|---|---|---|---|
Systolic BP (mmHg) | 140 ± 19 | 140 ± 21 | 0.99 |
Diastolic BP (mmHg) | 78 (66–83) | 73 (63–81) | 0.29 |
Haemoglobin (mg/dL) | 109 (99–118) | 109 (104–115) | 0.65 |
Urea Reduction Ratio (%) | 71.8 ± 8.4 | 72.3 ± 7.3 | 0.70 |
30-day mean ultrafiltration volume (ml) | 1718 ± 905 | 1703 ± 937 | 0.93 |
Post HD weight (kg) | 65.6 (60.5–82.4) | 66.2 (59.7–80.4) | 0.15 |
Albumin (g/L) | 33.5 (32–35) | 35 (33.8–36.3) | 0.08 |
Phosphate (mmol/L) | 1.73 ± 5.4 | 1.69 ± 5.3 | 0.59 |
Corrected Calcium (mmol/L) | 2.30 ± 0.12 | 2.29 ± 0.13 | 0.96 |
Highly sensitive Troponin T (pg/L)* | 38.8 (24.5–49.5) | 30.8 (18.9–57.6) | 0.02 |
NT-ProBNP (pg/ml)* | 3348 (1718–5112) | 2317 (1559–7028) | 0.43 |
Ejection Fraction (%) | 64.3 ± 10.0 | 61.7 ± 9.9 | 0.13 |
End Diastolic Volume (ml) | 143.2 (136.7–157.6) | 146.9 (127–168) | 0.78 |
End Systolic Volume (ml) | 50.9 (40.7–58.4) | 53.1 (42.2–64.6) | 0.16 |
Stroke Volume (ml) | 95.9 ± 21.9 | 90.6 ± 17.5 | 0.15 |
Left Ventricular Mass (g) | 139.1 (112.4–163.7) | 114.0 (100.9–155) | <0.001 |
LVMI (g/m 2 ) | 78.8 ± 18.6 | 69.9 ± 19.3 | <0.001 |
Global Longitudinal Strain (%) | −17.9 ± 5.3 | −21.6 ± 6.1 | <0.001 |
Strain Rate (s −1 ) | 0.97 ± 0.28 | 1.184 ± 0.46 | 0.01 |
Early Diastolic Strain Rate (s−1) | 1.04 ± 0.33 | 1.16 ± 0.43 | 0.15 |
Global T1 Time (ms) | 1263.4 ± 24.8 | 1259.3 ± 32.2 | 0.59 |
Septal T1 Time (ms) | 1277.4 ± 28.2 | 1271.5 ± 35.4 | 0.50 |
